JewishStatusOpen the app

Jewish News 24 · Nov 11, 2026

Jewish News 24 — photo status

💊 FDA APPROVES GROUNDBREAKING NEW DRUG TO PREVENT REPEAT STROKES: The FDA has approved Bayer’s Sunharbo (asundexian), the first drug in a new class of blood thinners designed to reduce the risk of another stroke. In a major clinical trial involving 12,327 patients, the once-daily pill reduced the relative risk of recurrent ischemic strokes by 26% when added to standard treatment, without a statistically significant overall increase in major bleeding. Approved November 9, the medication is intended for adults recovering from certain types of strokes or high-risk mini-strokes, marking a significant advancement in stroke prevention. The FDA cautioned that bleeding risks were higher in some patients, particularly those over 75.

💊 FDA APPROVES GROUNDBREAKING NEW DRUG TO PREVENT REPEAT STROKES: The FDA has approved Bayer’s Sunharbo (asundexian), the first drug in a new class of blood thinners designed to reduce the risk of another stroke. In a major clinical trial involving 12,327 patients, the once-daily pill reduced the relative risk of recurrent ischemic strokes by 26% when added to standard treatment, without a statistically significant overall increase in major bleeding. Approved November 9, the medication is intended for adults recovering from certain types of strokes or high-risk mini-strokes, marking a significant advancement in stroke prevention. The FDA cautioned that bleeding risks were higher in some patients, particularly those over 75.

Watch in the app All of Jewish News 24's statuses

More from Jewish News 24